226 related articles for article (PubMed ID: 20021568)
1. Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale.
van Nes SI; Vanhoutte EK; Faber CG; Garssen M; van Doorn PA; Merkies IS;
J Peripher Nerv Syst; 2009 Dec; 14(4):268-78. PubMed ID: 20021568
[TBL] [Abstract][Full Text] [Related]
2. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.
van Nes SI; Vanhoutte EK; van Doorn PA; Hermans M; Bakkers M; Kuitwaard K; Faber CG; Merkies IS
Neurology; 2011 Jan; 76(4):337-45. PubMed ID: 21263135
[TBL] [Abstract][Full Text] [Related]
3. Rasch analysis of the Fatigue Severity Scale in multiple sclerosis.
Mills R; Young C; Nicholas R; Pallant J; Tennant A
Mult Scler; 2009 Jan; 15(1):81-7. PubMed ID: 18755824
[TBL] [Abstract][Full Text] [Related]
4. Measuring fatigue in Parkinson's disease: a psychometric study of two brief generic fatigue questionnaires.
Hagell P; Höglund A; Reimer J; Eriksson B; Knutsson I; Widner H; Cella D
J Pain Symptom Manage; 2006 Nov; 32(5):420-32. PubMed ID: 17085268
[TBL] [Abstract][Full Text] [Related]
5. Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group.
Merkies IS; Schmitz PI; Samijn JP; van der Meché FG; van Doorn PA
Neurology; 1999 Nov; 53(8):1648-54. PubMed ID: 10563607
[TBL] [Abstract][Full Text] [Related]
6. Internal construct validity of the Oxford Knee Scale: evidence from Rasch measurement.
Conaghan PG; Emerton M; Tennant A
Arthritis Rheum; 2007 Dec; 57(8):1363-7. PubMed ID: 18050174
[TBL] [Abstract][Full Text] [Related]
7. Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ).
Hermans MC; Faber CG; De Baets MH; de Die-Smulders CE; Merkies IS
Neuromuscul Disord; 2010 May; 20(5):310-8. PubMed ID: 20363134
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in inflammatory neuropathies: the IN-QoL.
Draak THP; Faber CG; Merkies ISJ;
J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):256-262. PubMed ID: 28986470
[TBL] [Abstract][Full Text] [Related]
9. Fatigue and daytime sleepiness scale in myotonic dystrophy type 1.
Hermans MC; Merkies IS; Laberge L; Blom EW; Tennant A; Faber CG
Muscle Nerve; 2013 Jan; 47(1):89-95. PubMed ID: 23042586
[TBL] [Abstract][Full Text] [Related]
10. Construct validity and test-retest reliability of the Fatigue Severity Scale in people with chronic neck pain.
Takasaki H; Treleaven J
Arch Phys Med Rehabil; 2013 Jul; 94(7):1328-34. PubMed ID: 23274223
[TBL] [Abstract][Full Text] [Related]
11. Psychometric properties of the Fatigue Severity Scale: Rasch analyses of responses in a Norwegian and a Swedish MS cohort.
Lerdal A; Johansson S; Kottorp A; von Koch L
Mult Scler; 2010 Jun; 16(6):733-41. PubMed ID: 20558503
[TBL] [Abstract][Full Text] [Related]
12. Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
Draak TH; Gorson KC; Vanhoutte EK; van Nes SI; van Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
Eur J Neurol; 2016 Jul; 23(7):1248-53. PubMed ID: 27129110
[TBL] [Abstract][Full Text] [Related]
13. Reliability and validity of the Fatigue Severity Scale in Swedish for patients with systemic lupus erythematosus.
Mattsson M; Möller B; Lundberg Ie; Gard G; Boström C
Scand J Rheumatol; 2008; 37(4):269-77. PubMed ID: 18612927
[TBL] [Abstract][Full Text] [Related]
14. Psychometric properties of the Fatigue Severity Scale-Rasch analyses of individual responses in a Norwegian stroke cohort.
Lerdal A; Kottorp A
Int J Nurs Stud; 2011 Oct; 48(10):1258-65. PubMed ID: 21414620
[TBL] [Abstract][Full Text] [Related]
15. Fatigue as the main presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy: a study of 11 cases.
Boukhris S; Magy L; Gallouedec G; Khalil M; Couratier P; Gil J; Vallat JM
J Peripher Nerv Syst; 2005 Sep; 10(3):329-37. PubMed ID: 16221292
[TBL] [Abstract][Full Text] [Related]
16. Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP.
Comi C; Osio M; Ferretti M; Mesturini R; Cappellano G; Chiocchetti A; Carecchio M; Nascimbene C; Varrasi C; Cantello R; Mariani C; Monaco F; Dianzani U
J Peripher Nerv Syst; 2009 Jun; 14(2):101-6. PubMed ID: 19691532
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis.
Lamoureux EL; Pallant JF; Pesudovs K; Hassell JB; Keeffe JE
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4732-41. PubMed ID: 17065481
[TBL] [Abstract][Full Text] [Related]
18. Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
Draak TH; Vanhoutte EK; van Nes SI; Gorson KC; Van der Pol WL; Notermans NC; Nobile-Orazio E; Lewis RA; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; van den Berg LH; van Doorn PA; Cornblath DR; Faber CG; Merkies IS;
J Peripher Nerv Syst; 2015 Sep; 20(3):277-88. PubMed ID: 26110493
[TBL] [Abstract][Full Text] [Related]
19. Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness.
Draak TH; Vanhoutte EK; van Nes SI; Gorson KC; Van der Pol WL; Notermans NC; Nobile-Orazio E; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
Neurology; 2014 Dec; 83(23):2124-32. PubMed ID: 25378677
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal evaluation of the Center for Epidemiologic Studies-Depression scale (CES-D) in a rheumatoid arthritis population using Rasch analysis.
Covic T; Pallant JF; Conaghan PG; Tennant A
Health Qual Life Outcomes; 2007 Jul; 5():41. PubMed ID: 17629902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
